FemTech Market (2026 - 2033)

FemTech Market Summary

The global femtech market size was valued at USD 45.6 billion in 2025 and is projected to grow from USD 52.9 billion in 2026 to USD 145.5 billion in 2033, at a CAGR of 15.5% from 2026 to 2033. North America dominated the market, accounting for the largest share of 45.7% in 2025. The growth of the femtech industry is driven by rising awareness of women's health, the adoption of digital healthcare solutions, and the growing demand for technologies for fertility, pregnancy, menstrual, and menopause management.

In addition, the rising prevalence of infertility, PCOS, endometriosis, menopause-related conditions, and other reproductive health disorders is increasing the demand for femtech solutions. The growing adoption of mobile health applications, wearable devices, virtual care platforms, and AI-enabled diagnostic tools is improving access to personalized women’s healthcare. Companies such as Flo Health, Maven Clinic, Clue, Natural Cycles, Elvie, and Willow are strengthening their digital health offerings across fertility, menstrual health, pregnancy, menopause, and preventive care, thereby supporting the market expansion.

Rising investment in women’s health startups is also supporting market growth by enabling companies to expand their product portfolios, strengthen technology capabilities, and improve access to digital care solutions. For instance, Maven Clinic raised USD 125 million in Series F funding in October 2024, increasing its valuation to USD 1.7 billion. The funding is expected to support the expansion of AI-enabled women’s healthcare services, fertility benefits, menopause care, and global digital health solutions. In 2025, Maven further partnered with ŌURA to integrate wearable biometric data into personalized women’s healthcare, highlighting the growing role of connected health technologies in femtech.

Market Dynamics

Market Characteristics & Concentration

The chart below represents the relationship between industry concentration, industry characteristics, and industry participants. The femtech market remains fragmented, with numerous startups, digital health providers, medical device manufacturers, and healthcare platforms competing across fertility, pregnancy, menopause, menstrual health, pelvic care, and women's chronic disease management. The industry is characterized by a high degree of innovation, strong regulatory influence, moderately high levels of partnerships and collaborations, high service and product expansion, and high regional expansion. Growing investment in AI-enabled diagnostics, virtual care platforms, and personalized women's healthcare solutions continues to reshape the competitive landscape.

Strategic collaborations continue to strengthen product development, clinical validation, and commercialization across the femtech ecosystem. Partnerships between healthcare providers, technology companies, pharmaceutical firms, and digital health startups are helping expand access to women's healthcare services. In January 2025, Maven Clinic partnered with Amazon to provide comprehensive fertility, maternity, and menopause support for eligible employees through employer-sponsored healthcare benefits. Similarly, healthcare systems are increasingly collaborating with femtech companies to integrate virtual women's health services into routine clinical care, improving accessibility while supporting long-term market growth.

The femtech industry operates under stringent regulatory frameworks due to the clinical nature of many products, including medical devices, diagnostic software, and digital therapeutics. Regulatory approvals from agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) are essential before commercialization. In 2024, the FDA continued expanding oversight of AI-enabled Software as a Medical Device (SaMD), requiring robust clinical validation, cybersecurity, and lifecycle monitoring for AI-based diagnostic tools. These evolving regulatory requirements increase development costs but also improve product quality, safety, and market confidence.

Companies are rapidly expanding beyond fertility and pregnancy solutions into menopause care, pelvic health, breast health, cardiovascular risk assessment, mental health, hormonal disorders, and preventive care. In May 2025, Maven Clinic expanded its integrated digital care platform by introducing enhanced menopause and midlife health services alongside fertility and maternity offerings for employers and health plans. Similarly, several femtech companies launched AI-enabled screening tools, at-home diagnostics, and virtual care services to address previously underserved areas of women's health, significantly broadening the industry's service portfolio.

Integration of AI in the FemTech Industry

AI is transforming the FemTech industry by enabling more predictive, personalized, and data-driven women’s healthcare solutions. AI-powered platforms are increasingly being used for menstrual health management, fertility tracking, pregnancy monitoring, menopause care, and early disease detection, improving diagnostic accuracy and clinical decision-making.

For instance, in June 2026, Xella Health launched an AI-powered precision health platform focused on XX-chromosome biology to improve diagnostic accuracy and address gaps in women’s health research. Similarly, in June 2025, Flo Health adopted the Databricks Data Intelligence Platform to strengthen AI-driven cycle prediction and personalized health recommendations.

These developments highlight the growing role of AI in improving personalization, early intervention, user engagement, and data-driven care delivery across the industry.

Type Insights

The devices segment dominated the femtech market with a revenue share of 33.4% in 2025 and is expected to grow at the fastest CAGR of 15.70% during the forecast period. Growth is driven by the rising adoption of wearable devices for menstrual health, fertility tracking, pregnancy monitoring, and menopause management. Advancements in biosensors, AI, wireless connectivity, and real-time monitoring are further increasing demand for connected femtech devices.

For instance, in 2025, Movano Health advanced the commercialization of its Evie Ring. This women-focused smart ring tracks menstrual cycles, sleep, heart rate, blood oxygen levels, stress, and other health metrics, reflecting the growing demand for personalized, continuous health-monitoring solutions.

The software segment accounted for the second-largest market share in 2025 and is expected to grow significantly during the forecast period. Growth is supported by rising smartphone penetration, digital healthcare adoption, and increasing demand for AI-powered women’s health apps used for menstrual tracking, fertility planning, pregnancy support, menopause care, and virtual consultations.

For instance, in May 2025, HeraMED partnered with Teladoc Health to integrate its digital pregnancy monitoring platform with Teladoc’s virtual care ecosystem, supporting the growing use of software-enabled femtech solutions for remote pregnancy monitoring and personalized maternal care.

Application Insights

The pregnancy and nursing care segment dominated the femtech industry with a revenue share of 17.7% in 2025. Growth is driven by the increasing adoption of digital pregnancy monitoring, virtual maternity care, remote patient monitoring, and connected maternal health solutions. Companies are developing AI-enabled pregnancy apps, fetal monitoring devices, lactation support platforms, and personalized maternity care solutions to improve prenatal and postpartum care.

For instance, in May 2025, HeraMED partnered with Teladoc Health to integrate its remote pregnancy monitoring platform with Teladoc’s virtual care services. The partnership supports real-time fetal and maternal health monitoring, strengthening the adoption of digital prenatal care solutions and driving segment growth.

The menstrual health segment is expected to register the fastest CAGR of 16.3% during the forecast period. Growth is supported by rising awareness of menstrual health, increasing prevalence of PCOS and endometriosis, and growing demand for digital cycle-tracking solutions. Advances in AI, wearables, and personalized analytics are encouraging the adoption of menstrual health apps and connected devices.

For instance, in 2025, Flo Health expanded its AI-powered menstrual and reproductive health platform with enhanced cycle predictions, symptom analysis, and educational support. This reflects the growing demand for intelligent menstrual health solutions and supports the segment’s long-term growth.

End-use Insights

The direct-to-consumer segment dominated the femtech market with a revenue share of 30.7% in 2025 and is expected to register the fastest growth during the forecast period. Growth is driven by the convenience of online access, rising smartphone penetration, and increasing preference for personalized women’s health products and services. Consumers are increasingly using DTC platforms for fertility monitors, menstrual health apps, pregnancy care devices, menopause solutions, and wellness products.

For instance, in January 2025, Perelel Health expanded its personalized vitamin subscription platform with formulations for fertility, pregnancy, postpartum recovery, and menopause. This reflects the growing demand for convenient, subscription-based, and personalized women’s healthcare solutions, supporting DTC segment growth.

The hospitals segment is also expected to grow significantly during the forecast period. Hospitals are increasingly adopting femtech solutions for maternal care, reproductive health management, clinical decision support, and remote patient monitoring. For instance, in May 2025, HeraMED partnered with Teladoc Health to integrate remote pregnancy monitoring into Teladoc’s virtual care ecosystem, enabling clinicians to monitor maternal and fetal health remotely and improve access to personalized prenatal care.

Regional Insights

North America dominated the femtech market with a revenue share of 45.7% in 2025, driven by strong digital health adoption, advanced healthcare infrastructure, rising investment in women’s health, and the presence of leading femtech companies. Growing use of AI-powered platforms, wearable devices, and remote monitoring solutions is supporting regional growth. For instance, in January 2025, Willow Innovations launched the Willow Generation 4 Breast Pump with improved app connectivity and personalized pumping insights, reflecting the rising adoption of connected women’s health solutions.

U.S. Femtech Market Trends

The U.S. held the largest share of the North America femtech industry in 2025, supported by rising investment in digital women’s healthcare, virtual care adoption, fertility services, pregnancy monitoring, and menopause management platforms. For instance, in 2025, Maven Clinic expanded its AI-powered women’s health platform by strengthening maternity and menopause care services and employer partnerships, supporting market growth.

Asia Pacific Femtech Market Trends

The Asia Pacific femtech industry is expected to witness the fastest growth during the forecast period. The market is driven by increasing awareness of women's health, rapid digitalization of healthcare, rising smartphone penetration, and growing investments in femtech startups. Supportive government initiatives, improving healthcare infrastructure, and the growing adoption of AI-powered digital health solutions are further contributing to market growth across the region.

The China femtech market held a significant share of Asia Pacific in 2025. Growth is supported by rising demand for digital women’s healthcare, health technology investment, and local companies offering fertility, pregnancy, and menstrual health solutions. For instance, Babytree continued expanding its AI-enabled maternal and child healthcare platform, strengthening digital pregnancy management and online healthcare services.

The growth of the femtech market in India is driven by growing awareness of women’s health, digital healthcare adoption, startup activity, and government support for maternal and reproductive health. For instance, in 2025, NIRAMAI expanded the deployment of its AI-based breast cancer screening technology across hospitals and diagnostic centers, improving access to early and non-invasive screening.

Europe Femtech Market Trends

Europe is expected to grow significantly during the forecast period, supported by increasing investment in women’s health technologies, digital healthcare adoption, and product innovation across fertility, pregnancy, menopause care, menstrual health, pelvic health, and preventive care. For instance, in 2025, Elvie expanded its connected women’s health portfolio by enhancing app-based features across pelvic floor and breastfeeding solutions.

The UK femtech market is expected to grow significantly due to increasing investment, supportive healthcare initiatives, and innovation in women’s health technologies. Collaboration among the NHS, startups, and research organizations is supporting digital women’s healthcare. For instance, in 2025, the NHS expanded digital maternal health initiatives, strengthening the use of data and technology to improve maternity and women’s health services.

The femtech market in Germany held the largest share of Europe in 2025, driven by digital health adoption, supportive reimbursement policies, and investment in women’s health innovation. For instance, in 2025, Leona Health expanded its AI-powered platform for endometriosis diagnosis and care, supporting personalized digital disease management.

Latin America Femtech Market Trends

The Latin America femtech industry is expected to grow significantly during the forecast period due to increasing adoption of digital healthcare, rising awareness of women's health, and growing investment in health technology startups. The expansion of telehealth services, mobile health applications, and AI-enabled diagnostic solutions is creating new opportunities for femtech companies across the region.

The Brazil femtech market is expected to experience substantial growth, supported by increasing startup activity, digital health adoption, and demand for fertility, maternal health, and sexual wellness solutions. For instance, in 2025, the Women’s Health Innovation Summit Brazil brought together healthcare providers, startups, investors, and technology companies, highlighting the country’s expanding femtech ecosystem.

Middle East & Africa Femtech Market Trends

The Middle East & Africa femtech industry is expected to grow significantly due to improving digital healthcare infrastructure, increasing women’s health awareness, and rising investment in health technology. Government initiatives that support digital transformation and access to women’s healthcare are further driving market growth.

Key FemTech Company Insights

The market is highly fragmented, with the presence of many country-level service end uses. Some of the few startup players include Ava, Bloomlife, Bonzun, and Kegg.

Key FemTech Companies

The following key companies have been profiled for this study of the femtech market.

• Chiaro Technology Limited

• HeraMED

• Flo Health, Inc.

• Natural Cycles USA Corp

• Glow, Inc.

• Allara Health

• NUVO Inc.

• Bloomlife

• Syrona Health

• Sirona Hygiene Private Limited

• Samplytics Technologies Private Limited

• iSono Health, Inc.

• Athena Feminine Technologies

Competitive Benchmarking

Recent Developments

• In September 2025, Wellcome Leap and Pivotal Ventures announced a USD 100 million partnership to accelerate innovation in women's health. The initiative will support research and commercialization of technologies focused on reproductive health, gynecological disorders, maternal health, and chronic diseases that disproportionately affect women, helping address long-standing funding gaps in women's health innovation.

"This partnership reflects our commitment to accelerating scientific breakthroughs that improve women's health outcomes and close critical research gaps." - Wellcome Leap and Pivotal Ventures Joint Statement

• In October 2024, Maven Clinic secured USD 125 million in a Series F funding round, increasing its valuation to approximately USD 1.7 billion. The investment is being used to expand the company's global digital care platform across fertility, pregnancy, parenting, menopause, and women's health services while strengthening partnerships with employers and health plans.

"This investment enables us to expand access to comprehensive, virtual women's and family healthcare while supporting better health outcomes worldwide." - Kate Ryder, Founder and CEO, Maven Clinic

• In June 2023, University of Bath graduates launched a new app, Epowar, that revolutionizes safety for women walking alone. This wearable technology includes a safety app designed for women. It detects physical attacks, alerts chosen contacts, shares live location data, and stores evidence in the cloud, addressing personal safety concerns.

• In June 2023, MiMARK Diagnostic, a spin-off from the Vall d'Hebron Research Institute (VHIR) and based in the Barcelona Science Park, specializing in developing innovative solutions for gynecological diagnostics, raised USD 1.1 million in funding to advance the development of its endometrial cancer diagnostic test.

• In August 2021, Labcorp acquired Ovia Health, formerly known as Ovuline, a personalized data-driven solution for reproductive health companies. Through this acquisition, Labcorp strengthened its business position as a go-to source for women’s health insights and ventured into new avenues for personalized care.

• In March 2021, Clue received the U.S. FDA clearance for the launch of Clue Birth Control, a digital contraceptive built-in Clue application that can predict ovulation statistically by using a tool for birth control.

FemTech Market Report Scope

Global FemTech Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global femtech market report based on type, application, end-use, and region:

• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Devices

  • Software

  • Services

  • Consumer Products

• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Pregnancy and Nursing Care

  • Reproductive Health & Contraception

  • Menstrual Health

  • General Health

  • Pelvic & Uterine Health

  • Sexual Health

  • Women’s Wellness

  • Menopause Care

  • Longevity & Mental Health

• End-use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Direct to Consumer

  • Hospitals

  • Surgical Centers

  • Fertility Clinics

  • Diagnostic Centers

  • Others

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

    • Russia

    • Iceland

    • Finland

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

    • Singapore

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Israel

Research Methodology

The FemTech market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each FemTech segment quantified using the revenue-capture definitions in the table below.

Methodology Overview

The FemTech market size was estimated using a bottom-up approach, beginning with the identification of the potential target female population across key application areas. Market penetration rates for various FemTech products and services were then derived through secondary research and primary interviews. Average selling prices and service costs were analyzed across segments and regions. The target population, penetration rates, and pricing assumptions were integrated to estimate segment-level revenues, which were subsequently aggregated to derive the global FemTech market size and forecast.

Delivered Customizations

This report has been delivered with the following In-depth customizations